The FDA gave Zepbound “fast track” approval to study its uses for overweight or obese adults with comorbidities like sleep apnea in 2022, around when weight-loss drugs began growing in popularity.

FDA approves Zepbound, a new obesity drug that will take on Wegovy The FDA approval comes amid growing discussion about the potential uses of weight loss drugs beyond treating obesity and diabetes.

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s Wegovy in the first head-to-head study of the rival medicines.

Zepbound led to an average weight loss of 20.2 percent compared to Wegovy's 13.7 percent. We talked with healthcare experts to understand the study's findings, what sets these drugs apart and how ...

The Patients Forced to Switch From Zepbound to Wegovy Some shift to save money in response to CVS Caremark restrictions; others appeal for Zepbound coverage, citing better weight-loss results By ...

For more information, you can refer to Zepbound’s prescribing information. If you develop serious side effects while receiving Zepbound, call your doctor right away.

How Does Zepbound Reduce Weight? Tirzepatide works by activating two proteins called glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) which belong to a group ...

And do not stop using Zepbound unless your doctor recommends it. Zepbound may cause mild side effects other than those listed previously. See the drug’s prescribing information for details.

Zepbound is supplied in prefilled, single-dose pens that deliver doses of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg. The product is expected to be available by the end of 2023.

Zepbound, made by Eli Lilly, is the brand name for tirzepatide when used for weight loss. When the drug is prescribed for diabetes, it is sold under the brand name Mounjaro.

This section describes Zepbound’s typical dosage, but always follow the dosage your doctor prescribes. Form and strengths Zepbound comes as a liquid solution in prefilled, disposable injection ...

People who are commercially insured without coverage for Zepbound may be eligible to pay as low as $550 for a 1-month prescription of Zepbound, approximately 50% lower than the list price.